Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Key facts
- Where
- Daejeon, Dél-KoreaSee the site
Where in Dél-Korea
- Chungnam National University HospitaDaejeon, Dél-KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Chungnam National University Hospital
- Trial code
- NCT06519162
- Record updated
- 2026. március 20.
- Original description
In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.Read full original descriptionShow less
Exploration of Liver-gut Axis Through Identification of Liver Disease-specific Microbiome
In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.
Inclusion: Adults aged 19 years and older diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, who have consented to participate in this study at Chungnam National University Hospital; Adults aged 19 years and older, who are cohabitants of patients diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, and have consented to participate in this study at Chungnam National University Hospital; Exclusion.
Exclusion: Individuals under the age of 19; Patients or guardians who do not consent to participate in the study.